Gossamer Bio Inc. (NASDAQ:GOSS) went up by 0.59% from its latest closing price compared to the recent 1-year high of $15.19. The company’s stock price has collected -1.23% of loss in the last five trading sessions.
Is It Worth Investing in Gossamer Bio Inc. (NASDAQ :GOSS) Right Now?
Plus, the 36-month beta value for GOSS is at 0.91. Opinions of the stock are interesting as 9 analysts out of 11 who provided ratings for Gossamer Bio Inc. declared the stock was a “buy,” while 2 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $18.64, which is $4.5 above the current price. GOSS currently public float of 85.80M and currently shorts hold a 18.79% ratio of that float. Today, the average trading volume of GOSS was 1.46M shares.
GOSS’s Market Performance
GOSS stocks went down by -1.23% for the week, with a monthly drop of -3.20% and a quarterly performance of 93.46%, while its annual performance rate touched 32.68%. The volatility ratio for the week stands at 5.13% while the volatility levels for the past 30 days are set at 5.70% for Gossamer Bio Inc. The simple moving average for the period of the last 20 days is -3.20% for GOSS stocks with a simple moving average of 36.83% for the last 200 days.
Analysts’ Opinion of GOSS
Many brokerage firms have already submitted their reports for GOSS stocks, with Wedbush repeating the rating for GOSS by listing it as a “Outperform.” The predicted price for GOSS in the upcoming period, according to Wedbush is $24 based on the research report published on September 19th of the current year 2022.
Raymond James, on the other hand, stated in their research note that they expect to see GOSS reach a price target of $19. The rating they have provided for GOSS stocks is “Outperform” according to the report published on April 18th, 2022.
UBS gave a rating of “Buy” to GOSS, setting the target price at $19 in the report published on April 06th of the current year.
GOSS Trading at 5.86% from the 50-Day Moving Average
After a stumble in the market that brought GOSS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -10.50% of loss for the given period.
Volatility was left at 5.70%, however, over the last 30 days, the volatility rate increased by 5.13%, as shares sank -1.09% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +87.07% upper at present.
During the last 5 trading sessions, GOSS fell by -1.23%, which changed the moving average for the period of 200-days by +23.19% in comparison to the 20-day moving average, which settled at $14.04. In addition, Gossamer Bio Inc. saw 20.25% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at GOSS starting from Carter Laura, who purchase 6,934 shares at the price of $7.21 back on Jul 15. After this action, Carter Laura now owns 87,168 shares of Gossamer Bio Inc., valued at $49,994 using the latest closing price.
Christian Waage, the EVP, Tech Ops and Admin of Gossamer Bio Inc., purchase 6,934 shares at $7.21 during a trade that took place back on Jul 15, which means that Christian Waage is holding 13,888 shares at $49,994 based on the most recent closing price.
Stock Fundamentals for GOSS
Equity return is now at value -302.70, with -72.60 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 8.32.